Dutch firm argenx, J & J affiliate to collaborate on cancer therapy

Netherlands-based biopharmaceutical company argenx SE said it signed a deal with Cilag GmbH International, an affiliate of Johnson& Johnson's Janssen Pharmaceutical Companies unit, to develop its Cusatuzumab drug in certain types of cancer.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news